Schering Ag Articles
Bayer Looking for another major acquisition?
29 September 2010
Bayer tops most-visited European pharma web sites
22 September 2008
IBA buys 80% of CIS bio from IRE
9 June 2008
Bayer's 4th-qtr 2007 profit plummets 76% to 67M euros, well below analyst expectations
10 March 2008
Xanthus' oral fludarabine NDA accepted by FDA
4 February 2008
Bayer seeks more health acquisitons
10 December 2007
USA's HealthTrust signs 3-year renewal for Bayer's Magnevist
19 November 2007
Europe leads surge in Pharma M&A deal values
1 October 2007
Headlines 25 years ago this week....
18 June 2007
Bayer reorganizes US healthcare business
16 April 2007
Bayer and Novartis in MS drug deal
2 April 2007
Bayer's 2006 income climbs 5.4%
19 March 2007
Headlines 25 years ago this week....
12 March 2007
Bayer to save 700M euros pa via job cuts
12 March 2007
Japan's MHLW proposes "drug lag" solution
5 February 2007
Stock Commentary - Europe - week to Jan 15, 2007
22 January 2007
Headlines 25 years ago this week....
15 January 2007
Anti-TNF drug sales to hit $1.3B by 2015
22 December 2006
Squeeze out of minority Schering shareholders
11 December 2006
Schering AG buy boosts Bayer but charges take toll on profit; 3rd-qtr beats forecasts
4 December 2006
Betaferon OKed in Australia for earliest stages of MS
27 November 2006
Executive appoinmtnets at Organon BioSciences
13 November 2006
Go-ahead for Schering AG integration with Bayer
13 November 2006
Schering AG's Betaferon gets expanded US label
30 October 2006
Inpharmatica to develop kinase database for Schering AG
23 October 2006
Zevalin in aggressive Lymphoma trial
16 October 2006
FDA OKs new indiction for Schering AG's YAZ
9 October 2006
Betaferon cuts risk of developing MS
9 October 2006
Schering and Organon end R&D collaboration
25 September 2006
Schering AG outlicenses SEGRA drug to B&L
25 September 2006
Two EU majors agree SERD R&D deal
25 September 2006
Bayer HealthCare to invest $26M in China
11 September 2006
Schering AG contributions to Indonesia, Thailand reconstruction
11 September 2006
Bayer
4 September 2006
Stock Commentary - Europe - week to Aug 28, 2006
4 September 2006
Teva's Azilect approved for early PD in Canada
28 August 2006
Schering AG's Betaferon cuts risk of clinical MS
28 August 2006
Expanded Canada label for Berlex' Betaferon
14 August 2006
Stock Commentary - Europe - week to Aug 7, 2006
7 August 2006
Sargramostim falls short in Crohn's trials
7 August 2006
KPMG puts value of $21.12B on Schering AG
7 August 2006
Kinaxo and Schering AG agree R&D accord
31 July 2006
Takeover costs impact Schering AG's 1st-half 2006
31 July 2006
Merck KGaA's 2nd-qtr profit surges up 113%
31 July 2006
Takeover costs impact Schering's 1st-half 2006
26 July 2006
Final appro for Mylan's Estradiol strengths
26 July 2006
Schering AG enters AD diagnostics deal with Avid
24 July 2006
Genzyme's 2nd-qtr 2006 revenue rises 19%
24 July 2006
Jerini elects new supervisory board members
17 July 2006
Stock Commentary - Europe - week to July 10, 2006
17 July 2006
Bayer completes Schering AG takeover
17 July 2006
Bayer buys more shares in Schering AG
10 July 2006
Stock Commentary - Europe - week to July 3, 2006
10 July 2006
J&J wins bidding war for Pfizer
3 July 2006
Celera sells Cathepsin program to Schering
3 July 2006
Merck KGAA discontinues sarizotan after drug misses Ph III efficacy endpoints in PADDY-1/2
3 July 2006
Way clear for Bayer bid for Schering AG
26 June 2006
Serono reprimanded on ABPI Code breach
26 June 2006
Stock Commentary - Europe - week to June 12, 2006
19 June 2006
Merck KGaA moves to scupper Schering/Bayer marriage?
19 June 2006
Merck KGaA confirms 5%+ stake in Schering AG
12 June 2006
Stock Commentary - Europe - week to May 29, 2006
5 June 2006
Bayer extends Schering AG takeover period
5 June 2006
Schering AG starts Ph II ZK-EPO trials
29 May 2006
Stock Commentary - Europe - week to May 22, 2006
29 May 2006
EC OKs Bayer's buy of Schering AG
29 May 2006
Stock Commentary - Europe - week to May 15, 2006
22 May 2006
Schering AG's Betaferon gets thumbs up from CHMP
15 May 2006
Schering completes EU MRP for Yasminelle
15 May 2006
Stock Commentary - New York week to May 8, 2006
15 May 2006
Schering AG completes divestment of CIS bio
15 May 2006
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Italy's pharma market slump set to continue, warns GlobalData
- Is failure to adopt business process management putting the pharma industry at risk?
- Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
